The generation of a robust nonclinical data package is critical to thoroughly evaluate the safety and efficacy of innovative therapies, such as cell and gene therapies and vaccines, to enable regulatory success.
These novel medicines typically do not follow traditional development pathways but require a bespoke case-by-case approach based on a deep understanding of the science and a thorough assessment of the potential safety considerations.
We can expertly assist you in successfully navigating the nonclinical development pathway.
We provide the following nonclinical services:
- Nonclinical Strategy and De Novo Design
- Gap Analysis and Due Diligence
- Nonclinical Dossiers
- Regulatory Agency Meetings
Company Details
- Employees
- 1
- Founded
- -
- Address
- Whitstable, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.moaresolutions.co.uk
- Keywords
- ATMPs, Vaccines, Nonclinical Safety, Due Diligence, Gap Analysis, Translation, Regulatory Meetings, Consultancy, Immunology, Cell Therapies, Gene Therapies, Innovative Medicines, Strategy, Life Sciences, Specialist Adviser.
- HQ
- Whitstable
Moare Solutions Ltd Questions
Moare Solutions Ltd's website is http://www.moaresolutions.co.uk
Moare Solutions Ltd's LinkedIn profile is https://uk.linkedin.com/company/moare-solutions-ltd
Moare Solutions Ltd has
1 employees.
View email and phone details for 1
employees at Moare Solutions Ltd.
Moare Solutions Ltd's industry is
Biotechnology Research
Moare Solutions Ltd's top competitors are
Adjuvant Partners,
Oncolytika,
Goffin Consultancy,
Vitale Health Economics And Policy,
Polar Health Economics & Policy Consultancy,
Ev Therapeutics,
Ipsirius,
Splynt, Inc.,
Diligentlyai,
Lindville Bio.
Moare Solutions Ltd's categories are Biotechnology Research
Moare Solutions Ltd's founding year is 2020
